Percentage of patient visits, regardless of age, seen with a new occurrence of melanoma who have a treatment plan documented in the chart that was communicated to the physician(s) providing continuing care within one month of diagnosis.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patient visits with a treatment plan documented in the chart that was communicated to the physician(s) providing continuing care within one month of diagnosis
-
1.15 Denominator
All visits for patients, regardless of age, diagnosed with a new occurrence of melanoma
-
Exclusions
Documentation of patient reason(s) for not communicating treatment plan (eg, patient asks that treatment plan not be communicated physician(s) providing continuing care);
Documentation of system reason(s) for not communicating treatment plan to the primary care provider(s) (eg, patient does not have a primary care provider or referring physician)
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Cancer Endorsement Maintenance ProjectInitial EndorsementLast UpdatedRemoval Date
-
StewardPhysician Consortium for Performance ImprovementSteward Organization POC EmailSteward Organization Copyright
Physician Performance Measures (Measures) and related data specifications, developed by the American Medical Association
(AMA) in collaboration with the Physician Consortium for Performance Improvement (the Consortium) and the National
Committee for Quality Assurance (NCQA) pursuant to government sponsorship under subcontract 6205-05-054 with
Mathematica Policy Research, Inc. under contract 500-00-0033 with Centers for Medicare & Medicaid Services.
These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been
tested for all potential applications.
The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g.,
use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of
the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed
for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf
of the Consortium) or NCQA. Neither the AMA, NCQA, Consortium nor its members shall be responsible for any use of the
Measures.
THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.
© 2004-6 American Medical Association and National Committee for Quality Assurance. All Rights Reserved.
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should
obtain all necessary licenses from the owners of these code sets. The AMA, NCQA, the Consortium and its members disclaim all
liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.
CPT® contained in the Measures specifications is copyright 2005 American Medical Association.
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)
-